Citations

Citations to this article as recorded by  

• Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion
  Bao Zhang, Shenghan Wang, Zhichao Fu, Qiang Gao, Lin Yang, Zhentao Lei, Yuqiang Shi, Kai Le, Jie Xiong, Siyao Liu, Jiali Zhang, Junyan Su, Jing Chen, Mengyuan Liu, Beifang Niu
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
  Catherine S. Johnson, Leah M. Cook
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
  Clara Martori, Lidia Sanchez-Moral, Tony Paul, Juan Carlos Pardo, Albert Font, Vicenç Ruiz de Porras, Maria-Rosa Sarrias
  Cancers.2022; 14(2): 440.     CrossRef
• Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer
  Martin Lund, Torben B Pedersen, Søren Feddersen, Louise D Østergaard, Charlotte A Poulsen, Christian Enggaard, Mads H Poulsen, Lars Lund
  Research and Reports in Urology.2022; Volume 14: 33.     CrossRef
• Potential PET tracers for imaging of tumor-associated macrophages
  Bruna Fernandes, Paula Kopschina Feltes, Carolina Luft, Luiza Reali Nazario, Cristina Maria Moriguchi Jeckel, Ines F. Antunes, Philip H. Elsinga, Erik F. J. de Vries
  EJNMMI Radiopharmacy and Chemistry.2022;[Epub]     CrossRef
• Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study
  Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
  Japanese Journal of Clinical Oncology.2022;[Epub]     CrossRef
• Potential mechanisms ofPyrrosiae Foliumin treating prostate cancer based on network pharmacology and molecular docking
  Wen-Hua Guo, Kun Zhang, Lu-Hong Yang
  Drug Development and Industrial Pharmacy.2022; 48(5): 189.     CrossRef
• White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions
  Achinto Saha, Jill Hamilton-Reeves, John DiGiovanni
  Cancer and Metastasis Reviews.2022; 41(3): 649.     CrossRef
• Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer
  Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifu
  Biomedicines.2022; 10(10): 2369.     CrossRef
• Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?
  Sebastian Dommel, Matthias Blüher
  International Journal of Molecular Sciences.2021; 22(3): 1500.     CrossRef
• Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
  Mónica Macías, Ángel García-Cortés, Marcos Torres, Javier Ancizu-Marckert, Juan Ignacio Pascual, Fernando Díez-Caballero, José Enrique Robles, David Rosell, Bernardino Miñana, Beatriz Mateos, Daniel Ajona, Rodrigo Sánchez-Bayona, Oihane Bedialauneta, Susa
  Cytokine.2021; 141: 155471.     CrossRef
• Research Trends and Regulation of CCL5 in Prostate Cancer
  Renlun Huang, Lang Guo, Menghan Gao, Jing Li, Songtao Xiang
  OncoTargets and Therapy.2021; Volume 14: 1417.     CrossRef
• Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression
  Wei Bin Fang, Diana Sofia Acevedo, Curtis Smart, Brandon Zinda, Nadia Alissa, Kyle Warren, Garth Fraga, Li-Ching Huang, Yu Shyr, Wei Li, Lu Xie, Vincent Staggs, Yan Hong, Fariba Behbod, Nikki Cheng
  Scientific Reports.2021;[Epub]     CrossRef
• CCL2 (C-C Motif Chemokine Ligand 2) Biomarker Responses in Central Versus Peripheral Compartments After Focal Cerebral Ischemia
  Jingfei Shi, Wenlu Li, Fang Zhang, Ji Hyun Park, Hong An, Shuzhen Guo, Yunxia Duan, Di Wu, Kazuhide Hayakawa, Eng H. Lo, Xunming Ji
  Stroke.2021; 52(11): 3670.     CrossRef
• On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances
  Yiwu Yan, Su Yeon Yeon, Chen Qian, Sungyong You, Wei Yang
  International Journal of Molecular Sciences.2021; 22(24): 13537.     CrossRef
• Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
  Tetiana Hourani, James A. Holden, Wenyi Li, Jason C. Lenzo, Sara Hadjigol, Neil M. O’Brien-Simpson
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
  Nathan Karin
  Cancers.2021; 13(24): 6317.     CrossRef
• Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study
  Xiaohui Sun, Ding Ye, Lingbin Du, Yu Qian, Xia Jiang, Yingying Mao
  International Journal of Cancer.2020; 147(9): 2469.     CrossRef
• SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer
  Jungsug Gwak, Hayan Jeong, Kwanghyun Lee, Jee Yoon Shin, Taejun Sim, Jungtae Na, Jongchan Kim, Bong-Gun Ju
  Cancers.2020; 12(9): 2718.     CrossRef
• The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
  Nathan Karin
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
  Natalia Rybtsova, Tatiana Berezina, Alexander Kagansky, Stanislav Rybtsov
  Biomedicines.2020; 8(12): 615.     CrossRef
• Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine
  Orazio Schillaci, Manuel Scimeca, Donata Trivigno, Agostino Chiaravalloti, Simone Facchetti, Lucia Anemona, Rita Bonfiglio, Giuseppe Santeusanio, Virginia Tancredi, Elena Bonanno, Nicoletta Urbano, Alessandro Mauriello
  Nuclear Medicine and Biology.2019; 68-69: 66.     CrossRef
• Role of ALDH1A1 and HTRA2 expression to CCL2/CCR2 mediated breast cancer cell growth and invasion
  Qingting Hu, Megan Myers, Wei Fang, Min Yao, Gage Brummer, Justin Hawj, Curtis Smart, Cory Berkland, Nikki Cheng
  Biology Open.2019;[Epub]     CrossRef
• Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
  Takumi Kishimoto, Nobukazu Fujimoto, Takeshi Ebara, Toyonori Omori, Tetsuya Oguri, Akio Niimi, Takako Yokoyama, Munehiro Kato, Ikuji Usami, Masayuki Nishio, Kosho Yoshikawa, Takeshi Tokuyama, Mouka Tamura, Yoshifumi Yokoyama, Ken Tsuboi, Yoichi Matsuo, Ji
  BMC Cancer.2019;[Epub]     CrossRef
• RETRACTED: Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment
  Xiaolei Pei, Danfeng Zheng, Shaoping She, Zhiwei Fang, Shiying Zhang, Hao Hu, Kexin Xu, Ying Wang
  Frontiers in Oncology.2019;[Epub]     CrossRef
• More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
  Martha Gschwandtner, Rupert Derler, Kim S. Midwood
  Frontiers in Immunology.2019;[Epub]     CrossRef
• Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features
  Catarina Ferreira, João Lobo, Luís Antunes, Paula Lopes, Carmen Jerónimo, Rui Henrique
  Virchows Archiv.2018; 473(4): 443.     CrossRef
• Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes
  Jaroslaw Szczyrba, Volker Jung, Michaela Beitzinger, Elke Nolte, Sven Wach, Martin Hart, Sandra Sapich, Marc Wiesehöfer, Helge Taubert, Gunther Wennemuth, Norbert Eichner, Thomas Stempfl, Bernd Wullich, Gunter Meister, Friedrich A. Grässer
  Prostate Cancer.2017; 2017: 1.     CrossRef
• Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
  Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Alan Forrest, Alice C. Ceacareanu
  Data in Brief.2017; 11: 391.     CrossRef
• Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer
  Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Erin E. Davis, Alan Forrest, Alice C. Ceacareanu
  Data in Brief.2017; 11: 446.     CrossRef
• Activity and Functions of Tumor-associated Macrophages in Prostate Carcinogenesis
  Matteo Santoni, Liang Cheng, Alessandro Conti, Cinzia Mariani, Antonio Lopez-Beltran, Rodolfo Montironi, Nicola Battelli
  European Urology Supplements.2017; 16(12): 301.     CrossRef
• Association of mast cell infiltration with gastric cancer progression
  Bei Zhong, Yu Li, Xiaodong Liu, Dongsheng Wang
  Oncology Letters.2017;[Epub]     CrossRef
• Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer
  Tomomi Fujii, Keiji Shimada, Yoshihiro Tatsumi, Nobumichi Tanaka, Kiyohide Fujimoto, Noboru Konishi
  Molecular Carcinogenesis.2016; 55(9): 1378.     CrossRef
• Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
  Alessandro Sciarra, Alessandro Gentilucci, Stefano Salciccia, Federico Pierella, Flavio Del Bianco, Vincenzo Gentile, Ida Silvestri, Susanna Cattarino
  Journal of Inflammation.2016;[Epub]     CrossRef
• Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model
  Stefano Garetto, Claudia Sardi, Elisa Martini, Giuliana Roselli, Diego Morone, Roberta Angioni, Beatrice Claudia Cianciotti, Anna Elisa Trovato, Davide Giuseppe Franchina, Giovanni Francesco Castino, Debora Vignali, Marco Erreni, Federica Marchesi, Cristi
  Oncotarget.2016; 7(28): 43010.     CrossRef
• Inflammation and prostate cancer: friends or foe?
  Gianluigi Taverna, Elisa Pedretti, Giuseppe Di Caro, Elena Monica Borroni, Federica Marchesi, Fabio Grizzi
  Inflammation Research.2015; 64(5): 275.     CrossRef
• CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro
  Igor Tsaur, Jochen Rutz, Jasmina Makarević, Eva Juengel, Kilian M. Gust, Hendrik Borgmann, David Schilling, Karen Nelson, Axel Haferkamp, Georg Bartsch, Roman A. Blaheta
  World Journal of Urology.2015; 33(7): 1051.     CrossRef
• sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients
  Igor Tsaur, Kristina Thurn, Eva Juengel, Kilian M. Gust, Hendrik Borgmann, Rene Mager, Georg Bartsch, Elsie Oppermann, Hanns Ackermann, Karen Nelson, Axel Haferkamp, Roman A. Blaheta
  Journal of Experimental & Clinical Cancer Research.2015;[Epub]     CrossRef
• The Role of Biomarkers and Genetics in the Diagnosis of Prostate Cancer
  Firas Abdollah, Deepansh Dalela, Michael C. Haffner, Zoran Culig, Jack Schalken
  European Urology Focus.2015; 1(2): 99.     CrossRef